Temasek leads $50m Series B in digital health firm PEAR Therapeutics, EDBI joins round

A Temasek Holdings Pte employee walks past the company's signage in their office in Singapore, on Monday, June 11, 2012. Photographer: Munshi Ahmed/Bloomberg

Singapore’s state-run investment firm Temasek Holdings Private Ltd led a $50 million Series B investment in US-based digital health firm PEAR Therapeutics.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.